Haiquan Qiao

2.8k total citations
60 papers, 2.3k citations indexed

About

Haiquan Qiao is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Haiquan Qiao has authored 60 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 20 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Haiquan Qiao's work include Cancer-related molecular mechanisms research (9 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Angiogenesis and VEGF in Cancer (7 papers). Haiquan Qiao is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), Cancer, Hypoxia, and Metabolism (8 papers) and Angiogenesis and VEGF in Cancer (7 papers). Haiquan Qiao collaborates with scholars based in China, New Zealand and Australia. Haiquan Qiao's co-authors include Xueying Sun, Hongchi Jiang, Xian Jiang, Xuesong Dong, Shangha Pan, Bo Zhai, Gang Tan, Geoffrey W. Krissansen, Dali Zhao and Xuesong Dong and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Hepatology.

In The Last Decade

Haiquan Qiao

59 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haiquan Qiao China	29	1.2k	710	504	280	277	60	2.3k
Lianxin Liu China	27	1.4k 1.2×	1.1k 1.5×	533 1.1×	226 0.8×	212 0.8×	59	2.5k
Basabi Rana United States	26	1.2k 1.0×	313 0.4×	478 0.9×	223 0.8×	207 0.7×	58	2.0k
Liankang Sun China	31	1.4k 1.2×	996 1.4×	606 1.2×	200 0.7×	126 0.5×	55	2.2k
Satyanarayana Ande United States	25	1.3k 1.1×	313 0.4×	489 1.0×	172 0.6×	266 1.0×	44	2.5k
Aijuan Qu China	32	1.3k 1.1×	596 0.8×	252 0.5×	270 1.0×	174 0.6×	66	2.9k
Lionel Hebbard Australia	32	1.2k 1.0×	499 0.7×	489 1.0×	233 0.8×	326 1.2×	51	2.7k
Marco Colombi Switzerland	13	1.5k 1.2×	613 0.9×	309 0.6×	261 0.9×	95 0.3×	23	2.5k
Wen‐Lung Ma Taiwan	23	839 0.7×	480 0.7×	326 0.6×	112 0.4×	265 1.0×	68	1.9k
Mingjing Xu Hong Kong	20	1.2k 0.9×	742 1.0×	507 1.0×	470 1.7×	126 0.5×	38	2.3k

Countries citing papers authored by Haiquan Qiao

Since Specialization

Citations

This map shows the geographic impact of Haiquan Qiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiquan Qiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiquan Qiao more than expected).

Fields of papers citing papers by Haiquan Qiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiquan Qiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiquan Qiao. The network helps show where Haiquan Qiao may publish in the future.

Co-authorship network of co-authors of Haiquan Qiao

This figure shows the co-authorship network connecting the top 25 collaborators of Haiquan Qiao. A scholar is included among the top collaborators of Haiquan Qiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiquan Qiao. Haiquan Qiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Chen, et al.. (2022). Fluorophore-Conjugated Anti-ICOS Antibody Enables Precise Prediction of Therapeutic Response of the STING Agonist in Colorectal Cancer via NIRF Imaging. Molecular Pharmaceutics. 19(11). 3877–3883. 1 indexed citations

Zhou, Baoguo, Taotao Han, Hongpeng Jiang, et al.. (2016). MiR‐382 inhibits cell growth and invasion by targeting NR2F2 in colorectal cancer. Molecular Carcinogenesis. 55(12). 2260–2267. 35 indexed citations

Zhao, Dali, Bo Zhai, Changjun He, et al.. (2014). Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells. Cellular Signalling. 26(5). 1030–1039. 126 indexed citations

Zhai, Bo, Fengli Hu, Xian Jiang, et al.. (2014). Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 13(6). 1589–1598. 245 indexed citations

Dong, Xiaofeng, Rui Li, Peng Xiu, et al.. (2014). Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2- Dependent and -Independent Pathways. PLoS ONE. 9(3). e92864–e92864. 39 indexed citations

Ma, Li, Guangxin Li, Huaqiang Zhu, et al.. (2014). 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2. Cancer Letters. 355(1). 96–105. 85 indexed citations

Tang, Bo, Xuesong Dong, Zheng Wei, et al.. (2014). Enhanced Autophagy by Everolimus Contributes to the Antirestenotic Mechanisms in Vascular Smooth Muscle Cells. Journal of Vascular Research. 51(4). 259–268. 7 indexed citations

Sun, Bo, Haiquan Qiao, Yuli Wang, & Baoguo Zhou. (2013). No.16a2b1 lymph node dissection for advanced gastric cancer prolongs patients' survival. Zhonghua putong waike zazhi. 28(10). 744–747.

Dong, Xuesong, Lele Lin, Xian Jiang, et al.. (2013). Up‐regulation of survivin by AKT and hypoxia‐inducible factor 1α contributes to cisplatin resistance in gastric cancer. FEBS Journal. 281(1). 115–128. 77 indexed citations

10.

Jiang, Hongchi, et al.. (2013). Can the Spleen be Divided into Two Functional Parts?. Journal of Clinical Gastroenterology. 48(3). 261–263. 1 indexed citations

11.

Jiang, Xian, Fengjun Liu, Haiquan Qiao, et al.. (2012). Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo. Tumor Biology. 34(1). 181–192. 43 indexed citations

12.

He, Changjun, Haiquan Qiao, Xian Jiang, et al.. (2011). Downregulating hypoxia‐inducible factor‐2α improves the efficacy of doxorubicin in the treatment of hepatocellular carcinoma. Cancer Science. 103(3). 528–534. 54 indexed citations

13.

Jiang, Xian, Hali Li, Haiquan Qiao, et al.. (2009). Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice. Cancer Science. 100(11). 2226–2233. 21 indexed citations

14.

Wang, Yuli, Qinggang Meng, Haiquan Qiao, Hongchi Jiang, & Xueying Sun. (2009). Role of the Spleen in Cyclophosphamide-induced Hematosuppression and Extramedullary Hematopoiesis in Mice. Archives of Medical Research. 40(4). 249–255. 28 indexed citations

15.

Zhang, Feng, Liquan Tong, Haiquan Qiao, et al.. (2008). Taurine Attenuates Multiple Organ Injury Induced by Intestinal Ischemia Reperfusion in Rats. Journal of Surgical Research. 149(1). 101–109. 38 indexed citations

16.

Liu, Fengjun, Peijun Wang, Xian Jiang, et al.. (2008). Antisense hypoxia‐inducible factor 1α gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma. Cancer Science. 99(10). 2055–2061. 52 indexed citations

17.

Qiao, Haiquan, et al.. (2008). Downregulation of developmentally regulated endothelial cell locus-1 inhibits the growth of colon cancer. Journal of Biomedical Science. 16(1). 33–33. 22 indexed citations

18.

Liu, Bing, Shangha Pan, Xuesong Dong, et al.. (2006). Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice. Cancer Science. 97(7). 675–681. 90 indexed citations

19.

Ma, Lixin, Liqiong Luo, Haiquan Qiao, et al.. (2006). Complete eradication of hepatocellular carcinomas by combined vasostatin gene therapy and B7H3-mediated immunotherapy. Journal of Hepatology. 46(1). 98–106. 56 indexed citations

20.

Sun, Xueying, et al.. (2002). Beta7 integrins contribute to skin graft rejection.. Transplantation. 74(8). 1202–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact